India Globalization Capital Announces Financial Results for Quarter Ended June 30, 2015

Revenue Increases by 143% as Company Executes on Core Initiatives


BETHESDA, Md., Aug. 17, 2015 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE MKT:IGC) announced financial results for the first quarter of its 2016 fiscal year ended June 30, 2015.

Total revenue was $1,858,809 for Q1 2015 as compared to $763,864 for Q1 2014. The revenue reported for both quarters was primarily from selling electronics components to OEMs and the India based heavy equipment rental business. The revenue reported in fiscal Q1 2015 was higher due to an increase in the volume of business.

Selling, general and administrative expenses were $305,403 for Q1 2015 and $1,077,686 for Q1 2014. Our SG&A has been reduced as we have shed costs associated with non-performing businesses, including the mining of iron ore.

In Q1 2016, the Company reported a GAAP net income loss of $382,699 and a GAAP EPS loss of $0.03 compared to a GAAP net income loss of $1,201,429 and a GAAP EPS loss of $0.12 for Q1 2014. The improved performance for Q1 2016 is largely attributable to higher top line revenue with lower associated costs.

"We have made significant progress in developing our key operating segments during the quarter and continue to build a foundation where we have a strategic advantage and can leverage our international presence. During fiscal 2016, we are committed to advancing our core mandates which includes the creation of a portfolio of marijuana and hemp based patents where we can partner to create and ultimately file for FDA approval of cannabinoid-based drugs for compassionate use in high potential indications," said Ram Mukunda CEO of IGC.

About IGC:

Based in Bethesda, Maryland, IGC, Inc. is positioning itself in two of the world's fastest growing industries -- phytocannabinoid-based biopharmaceuticals and the Internet of Things ("IoT"). We supply electronic and health monitoring components to original equipment manufacturers (OEMs), and develop phytocannabinoid-based therapies for the treatment of a wide range of life altering conditions. In addition, we build leading edge facilities that can be used to grow and extract pharmaceutical grade phytocannabinoids. Our website: www.igcinc.us. Twitter @IGCIR.

Forward-looking Statements:

Some of the statements contained in this press release that are not historical facts constitute forward-looking statements under the federal securities laws. Forward-looking statements can be identified by the use of the words "may," "will," "should," "could," "expects," "plans," "anticipates," "believes," "estimates," "predicts," "intends," "potential," "proposed" or the negative of those terms. These statements are not a guarantee of future developments and are subject to risks, uncertainties, and other factors, some of which are beyond IGC's control and are difficult to predict. Consequently, actual results may differ materially from information contained in the forward-looking statements as a result of future changes or developments in IGC's business and acquisition and diversification strategy, competitive environment, infrastructure demands, and governmental, regulatory, political, economic, legal and social conditions in, among other places, China and India.

Except as required by federal securities laws, IGC undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information or future events, or otherwise. Other factors and risks that could cause or contribute to actual results differing materially from such forward-looking statements have been discussed in greater detail in IGC's Form 10-K for fiscal year ended March 31, 2015, and in subsequent reports filed with the U.S. Securities and Exchange Commission.

     
INDIA GLOBALIZATION CAPITAL, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
     
  All amounts in USD except share data
  As of
  30-Jun-15 31-Mar-15
  (unaudited) (audited)
ASSETS    
Current assets:    
Cash and cash equivalents $ 659,597 $ 824,492
Accounts receivable, net of allowances 1,025,338 993,296
Inventories 1,271,746 709,649
Prepaid expenses and other current assets 1,907,956 1,950,295
Total current assets $ 4,864,637 $ 4,477,732
Goodwill 982,782 982,782
Intangible assets 306,205 306,131
Property, plant and equipment, net 7,654,131 7,784,447
Investments in affiliates 5,997,058 5,997,058
Investments-others 29,863 30,477
Deferred income taxes 318,153 318,548
Other non-current assets 426,933 434,284
Total long-term assets $ 15,715,125 $ 15,853,727
Total assets $ 20,579,762 $ 20,331,459
LIABILITIES AND STOCKHOLDERS' EQUITY    
Current liabilities:    
Short-term borrowings 1,277,812 1,280,356
Trade payables 425,849 174,584
Accrued expenses 366,171 422,252
Loans - others 111,919 73,707
Other current liabilities 412,098 496,985
Total current liabilities $ 2,593,849 $ 2,447,884
Long-term borrowings 308,202 323,904
Notes payable 2,135,000 1,800,000
Other non-current liabilities 1,020,512 1,009,889
  $ 3,463,714 $ 3,133,793
Total liabilities $ 6,057,563 $ 5,581,677
Stockholders' equity:    
Common stock — $0.0001 par value; 150,000,000 shares authorized; 14,766,333 issued and outstanding as of March 31, 2015 and 14,991,798 issued and outstanding as of June 30, 2015. $ 1,499 $ 1,477
Additional paid-in capital 63,576,206 63,479,918
Accumulated other comprehensive income (1,883,531) (1,913,585)
Retained earnings (Deficit) (47,716,580) (47,333,955)
Total equity attributable to Parent $ 13,977,594 $ 14,233,855
Non-controlling interest $ 544,605 $ 515,927
Total stockholders' equity $ 14,522,199 $ 14,749,782
Total liabilities and stockholders' equity $ 20,579,762 $ 20,331,459
     

These interim financial statements should be read in conjunction with the financial statements and notes included in the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2015 and Annual Report on Form 10-K for the fiscal year ended March 31, 2015. Quarterly financial results may not be indicative of the financial results for the entire fiscal year.

     
INDIA GLOBALIZATION CAPITAL, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
     
  All amounts in USD except share
data
  Three months ended June 30,
  2015 2014
     
Revenues $ 1,858,809 $ 763,864
Cost of revenues (excluding depreciation) (1,654,769) (687,288)
Selling, general and administrative expenses (305,403) (1,077,686)
Depreciation (155,974) (148,889)
Impairment loss - Investment others    
Operating income (loss) $ (257,337) $ (1,149,999)
Interest expense (61,914) (61,170)
Interest income 694 2,338
Other income, net (35,057) (887)
Income before income taxes and minority interest attributable to non-controlling interest $ (353,614) $ (1,209,718)
Income taxes benefit/(expense) -- --
Net income/(loss) $ (353,614) $ (1,209,718)
Non-controlling interests in earnings of subsidiaries 29,085 (8,289)
Net income/(loss) attributable to common stockholders $ (382,699) $ (1,201,429)
Earnings/(loss) per share attributable to common stockholders:    
Basic $ (0.03) $ (0.12)
Diluted $ (0.03) $ (0.12)
Weighted-average number of shares used in computing earnings per share amounts:    
Basic 14,832,065 10,174,358
Diluted 14,832,065 10,174,358
     

These interim financial statements should be read in conjunction with the financial statements and notes included in the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2015 and Annual Report on Form 10-K for the fiscal year ended March 31, 2015. Quarterly financial results may not be indicative of the financial results for the entire fiscal year.



            

Contact Data